GIP/GLP-1 双受体激动剂在 T2DM 中创新机制AIKAPOSI发布于 2024-10-11 · 浏览 312 · 来自 Android · IP 山东山东https://hao.dxy.cn/plus/promotion/invite/3712040541740072960/eyJpdiI6InlzUm9BUzdmUDFra2U0aFRTL3JSYVE9PSIsInZhbHVlIjoiRkdoQnJHblRYK1g3RE5Hcm9vM2NEdjNtYy95bW5oUWNoL3hhb1JQcjduUkV0bWt2akllNTFZdzBML1hmNWo5eDR4NThVeUF0RUczaWhVWDgrUVk4a0FXMkhIb0dnRDhHL3hXcUgrUEp2ZE9kMXUvMXhIQWJyNFVaTlpCbktQL3EiLCJtYWMiOiI2NGFlY2E1MmI0NjdiMTgyNDQyZTQ4ZWY5NGU3NDliMTM5NmM2Nzg4YTQyZWIxMGY4ODIxZjdlNGVkNmVlYjI3IiwidGFnIjoiIn0=?sf=1&sr=1 最后编辑于 2024-10-11 · 浏览 312 回复收藏3